Panel Discussion: Business Development Perspectives on the Oligonucleotides Space
Time: 2:30 pm
day: Day Two
Details:
- Exploring historical trends in business development and financing for oligonucleotide therapeutics
- Uncovering the challenges and opportunities these trends present for those attempting to innovate within this disease area
- Explaining what investors need to see in order to invest
- Perspectives on the need to demonstrate both mechanistic understanding and a regulatory pathway through to the market
